Showing results (111-120 of 366) with videos related to
Sort By:
Pageof 37
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1980
[Immune response in the course of Kaposi's sarcoma]G Scalise, M S Mura, C Piersimoni, et al.Gait & Posture|January 13, 2001
Quantitative analysis of neutral body posture in prolonged microgravityG Andreoni, C Rigotti, G Baroni, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 1, 1995
Cancer of the cervix, FIGO stages IB and IIA: patterns of local growth and paracervical extensionF. Landoni, L. Bocciolone, P. Perego, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 7, 1999
Emergence of p53 mutant cisplatin-resistant ovarian carcinoma cells following drug exposure: spontaneously mutant selectionS C Righetti, P Perego, E Corna, et al.Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|September 14, 2013
Microbial production of biovanillinA Converti, B Aliakbarian, J M Domínguez, et al.Cancer Chemotherapy and Pharmacology|April 2, 1998
In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systemsS Romanelli, P Perego, G Pratesi, et al.Bollettino Dell'Istituto Sieroterapico Milanese|July 31, 1979
[Cytogenic analysis in HBsAg positive subjects, healthy carriers and patients with acute-phase hepatitis]M G Vianello, L C Fasce, M S Mura, et al.Current Cancer Drug Targets|February 7, 2003
Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repairS Manic, L Gatti, N Carenini, et al.Pharmacology & Therapeutics|April 16, 1998
Role of apoptotic response in cellular resistance to cytotoxic agentsF Zunino, P Perego, S Pilotti, et al.Pharmacological Reviews|December 21, 2000
Yeast mutants as a model system for identification of determinants of chemosensitivityP Perego, G S Jimenez, L Gatti, et al.Pageof 37